Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Texas Instruments
TXN
|
$638M |
| 2 |
Broadcom
AVGO
|
$602M |
| 3 |
Tesla
TSLA
|
$492M |
| 4 |
American International
AIG
|
$465M |
| 5 |
Advanced Micro Devices
AMD
|
$421M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$426M |
| 2 |
Pinduoduo
PDD
|
$393M |
| 3 |
DexCom
DXCM
|
$367M |
| 4 |
Synopsys
SNPS
|
$350M |
| 5 |
Manhattan Associates
MANH
|
$290M |
Sector Composition
| 1 | Technology | 23.41% |
| 2 | Financials | 12.14% |
| 3 | Industrials | 11.35% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
KalVista Pharmaceuticals
KALV
$796M
| $165K | ﹤0.01% |
+13,477
| New | +$165K |
|
3477
Playboy, Inc. Common Stock
PLBY
$187M
| $163K | ﹤0.01% |
162,879
+1,836
| +1% | +$1.84K |
|
3478
Voyager Therapeutics
VYGR
$235M
| $162K | ﹤0.01% |
19,204
-15,403
| -45% | -$130K |
|
|
MACK
3479
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $162K | ﹤0.01% |
+12,066
| New | +$162K |
|
|
LUCK
3480
Lucky Strike Entertainment Corporation
LUCK
$1.4B
| $161K | ﹤0.01% |
11,394
-11,633
| -51% | -$165K |
|
3481
Vital Farms
VITL
$2.28B
| $160K | ﹤0.01% |
10,218
-21,573
| -68% | -$338K |
|
|
HIE
3482
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $159K | ﹤0.01% |
15,029
-10
| -0.1% | -$106 |
|
3483
Grindr
GRND
$2.94B
| $159K | ﹤0.01% |
18,145
-2,797
| -13% | -$24.6K |
|
3484
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $158K | ﹤0.01% |
47,397
+9,311
| +24% | +$31K |
|
3485
Novavax
NVAX
$1.28B
| $158K | ﹤0.01% |
32,852
-1,817
| -5% | -$8.72K |
|
3486
AXT Inc
AXTI
$143M
| $157K | ﹤0.01% |
65,403
+748
| +1% | +$1.8K |
|
|
AEF
3487
abrdn Emerging Markets Equity Income Fund
AEF
$251M
| $155K | ﹤0.01% |
30,332
-15
| -0% | -$77 |
|
|
CHI
3488
Calamos Convertible Opportunities and Income Fund
CHI
$816M
| $154K | ﹤0.01% |
14,856
-7,376
| -33% | -$76.4K |
|
3489
Biote Corp
BTMD
$110M
| $152K | ﹤0.01% |
30,795
+570
| +2% | +$2.82K |
|
|
SLRN
3490
DELISTED
ACELYRIN
SLRN
| $152K | ﹤0.01% |
20,350
+2,397
| +13% | +$17.9K |
|
3491
UroGen Pharma
URGN
$873M
| $152K | ﹤0.01% |
10,102
+47
| +0.5% | +$705 |
|
3492
Evolus
EOLS
$495M
| $151K | ﹤0.01% |
14,363
-2,624
| -15% | -$27.6K |
|
3493
Biomea Fusion
BMEA
$114M
| $149K | ﹤0.01% |
10,262
-7,762
| -43% | -$113K |
|
|
CDMO
3494
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $149K | ﹤0.01% |
22,913
-205,413
| -90% | -$1.34M |
|
3495
Spruce Power Holding Corp
SPRU
$27.3M
| $149K | ﹤0.01% |
33,670
+449
| +1% | +$1.99K |
|
3496
Xeris Biopharma Holdings
XERS
$1.27B
| $148K | ﹤0.01% |
63,177
-256,471
| -80% | -$603K |
|
|
EVA
3497
DELISTED
Enviva Inc.
EVA
| $148K | ﹤0.01% |
148,524
-114,619
| -44% | -$114K |
|
3498
Urban One Class D
UONEK
$42.7M
| $146K | ﹤0.01% |
+41,372
| New | +$146K |
|
3499
SoundHound AI
SOUN
$5.81B
| $145K | ﹤0.01% |
68,309
-21,381
| -24% | -$45.3K |
|
|
RERE
3500
ATRenew
RERE
$968M
| $144K | ﹤0.01% |
75,219
-8,423
| -10% | -$16.2K |
|